Eli Lilly partners with Nvidia to build the pharma industry’s most powerful AI supercomputer, aiming to speed up drug discovery and innovation.

Somehow, it’s becoming even harder to get a GLP-1.

Lilly King won three Olympic gold medals and dozens of others in world competition before retiring in 2025. Here is her next ...

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Nvidia shares picked up strength in afternoon trading, rising 5.5% and pushing the AI chip giant's market value above $4.9 trillion for the first time, according to Dow Jones Market Data. Behind the ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.

New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include manufacturing, medical imaging and ...

Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...

In advance of CPhI, Cambrex and Wilmington PharmaTech both just announced big investments in US plants that make active ...

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

Nvidia announced on Tuesday that drugmaker Lilly is developing an AI system using more than 1,000 Blackwell Ultra chips.

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...